Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  EnteroMedics Inc    ETRM   US29365M2089

ENTEROMEDICS INC (ETRM)

12
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/25/2014 09/26/2014 09/29/2014 09/30/2014 10/01/2014 Date
1.12(c) 1.13(c) 1.23(c) 1.23(c) 1.1972 Last
541 124 325 578 640 895 268 361 147 719 Volume
-3.45% +0.89% +8.85% 0.00% -2.67% Change
More quotes
Company
EnteroMedics, Inc. is a clinical development stage medical device company with approvals to commercially launch its product in Australia and the European Economic Area.It's focused on the designs and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and... 
Surperformance© rating of EnteroMedics Inc
Trading Rating : Investor Rating :
More about the company
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 0,86 M
EBIT 2014 -28,4 M
Net income 2014 -29,0 M
Debt 2014 17,5 M
Yield 2014 -
Sales 2015 7,81 M
EBIT 2015 -30,4 M
Net income 2015 -31,0 M
Debt 2015 10,2 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 118x
EV / Sales 2015 12,1x
Capitalization 84,7 M
More Financials
Latest news on ENTEROMEDICS INC
09/05 ENTEROMEDICS : Assigned Patent
09/03 ENTEROMEDICS : Journal of the American Medical Association Publishes EnteroMedic..
08/28 ENTEROMEDICS : Announces Three Year Diabetes, Hypertension and Weight Loss Data ..
08/07 ENTEROMEDICS : Results of Operations and Financial Condition, Financial Statemen..
07/10 ENTEROMEDICS : Assigned Patent
07/09 ENTEROMEDICS : Patent Issued for Systems for Regulation of Blood Pressure and He..
07/02 ENTEROMEDICS : Patent Application Titled "Controlled Vagal Blockage Therapy" Pub..
06/26 ENTEROMEDICS : Updates on FDA Advisory Committee Recommendation
06/25 ENTEROMEDICS : Change in Directors or Principal Officers (form 8-K)
06/20 ENTEROMEDICS : Other Events, Financial Statements and Exhibits (form 8-K)
06/18 ENTEROMEDICS : Other Events, Financial Statements and Exhibits (form 8-K)
06/17 ENTEROMEDICS : Announces FDA Advisory Committee Recommendation on VBLOC(R) Vagal..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF